(800)525-7111 Free Consultation

Blog Archives

FDA Expands Losartan Recall Over Possible Cancer Risk

June 18, 2019   |  
Drug manufacturer Teva Pharmaceutical and the Food & Drug Administration (FDA) have expanded a voluntary recall of losartan potassium tablets, a common medication used to treat high blood pressure, based on contamination by potentially cancer-causing impurity called NMBA. N-Nitroso-N-methyl-4-aminobutyric acid (NMBA) is believed to increase the risk of cancer to patients...
Read More